#  Harvard Law School 

 



 ##  

  expand\_more  

 
  

 

[Harvard Law School ](https://hls.harvard.edu/)(HLS) is home to a number of faculty whose work relates closely to global health law, policy, and innovation. It features research programs on myriad topics related to global health and development, including racial justice, East Asian legal studies, environmental policies, human rights, law and economics, labor and health law, food law and policy, animal law, biotechnology and bioethics, corporate governance, entrepreneurship and venture finances, negotiation and dispute resolution, and also law and the sciences of the mind, brain, cognition, and behavior. HLS centers, institutes, and programs that engage with key aspects of global health include, for example, the [Berkman Center for Internet and Society](https://cyber.harvard.edu/), the [Harvard Immigration and Refugee Clinical Program](https://hls.harvard.edu/dept/clinical/clinics/harvard-immigration-and-refugee-clinical-program), the [Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics](http://petrieflom.law.harvard.edu), and the HLS [Program on Negotiation](https://www.pon.harvard.edu/).



 

### Featured Resource 

 

This [article](https://news.harvard.edu/gazette/story/2026/01/ai-is-speeding-into-healthcare-who-should-regulate-it/) from the Harvard Gazette presents a Q&A with I. Glenn Cohen, faculty director of the Petrie-Flom Center, on the challenges of regulating AI in healthcare. Cohen highlights the need for regulation and guidelines but also discusses how regulation should be balanced to ease the regulatory and financial burdens on smaller hospital systems and avoid slowing down a potentially game-changing technology.



 



      ![Close-up iron gate door.](/sites/g/files/omnuum10866/files/styles/hwp_1_1__480x480/public/2025-08/f1-law-schools-at-harvard.jpg?itok=_TWBoGG2) 

 

 

  

 



 

 

 

### Featured Resource 

 

This [article](https://hls.harvard.edu/today/marijuana-research-revival/) from Harvard Law School speaks with Carmel Shachar about the recent executive order that instructs federal agencies to begin reclassifying cannabis to Schedule III, which would allow cannabis to be prescribed by a doctor. Shachar explains how this move signals there will be more opportunity to research therapeutic uses of cannabis, such as for treating depression or post-traumatic stress disorder.



 



      ![Iron gate with leaves in the background.](/sites/g/files/omnuum10866/files/styles/hwp_1_1__480x480/public/2025-08/f2-law-schools-at-harvard.jpg?itok=IghYgxOs) 

 

 

  

 



 

 

 

 



 

 See also:- [ School ](/page-type/school)